📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Aarti Industries Secures USD 150 Million Supply Contract with Global Agrochemical Major
Aarti Industries has entered into a significant multi-year supply agreement with a leading global agrochemical innovator for a critical intermediate used in crop protection. The contract is valued at approximately USD 150 million and is set to run through March 31, 2030. This agreement transitions a previous annual engagement into a structured, high-volume long-term contract. It provides the company with enhanced revenue visibility and strengthens its strategic position in the global agrochemical supply chain.
Key Highlights
Total contract value estimated at approximately USD 150 million over the term.
Agreement extends through March 31, 2030, providing medium-to-long term revenue visibility.
Involves the supply of a critical agrochemical intermediate to a top-tier global innovator.
The contract represents a significant increase in volumes compared to previous annual engagements.
Awarded by an international entity with no promoter or related party interest involved.
💼 Action for Investors
Investors should view this as a strong positive for long-term growth and earnings stability. Maintain a positive outlook on the stock while monitoring the company's ability to scale production to meet these increased volume requirements.
Aarti Industries Bags $150 Million Supply Contract with Global Agrochemical Major
Aarti Industries Limited (AIL) has secured a multi-year supply agreement worth approximately USD 150 million with a top global agrochemical innovator. The contract, which runs through March 31, 2030, involves the supply of a critical agrochemical intermediate used in crop protection. This agreement represents a significant volume increase over previous engagements and provides strong revenue visibility for the medium to long term. Importantly, AIL will fulfill this contract using existing capacities, requiring no incremental capital expenditure.
Key Highlights
Total contract value estimated at USD 150 million over the period ending March 2030
Agreement involves a significant increase in supply volumes compared to current annual levels
No incremental capex required as the company will utilize existing adequate manufacturing capacities
Strengthens AIL's position as a strategic partner for global agrochemical innovators
💼 Action for Investors
This is a positive development that enhances long-term earnings visibility and improves capacity utilization without additional debt or investment. Investors should maintain a positive outlook as this validates the company's competitive edge in the global specialty chemicals supply chain.
Aarti Industries to Invest ₹200-250 Cr for Backward Integration in Global Supply Deal
Aarti Industries has amended a long-term supply agreement with a leading global chemical company to undertake a strategic backward integration project. The company will invest ₹200–250 crores over the next two years to manufacture a critical feedstock in-house at its Dahej SEZ facility. While the move is not expected to significantly impact topline growth, it is projected to enhance EBITDA margins through operational efficiencies. This integration will benefit the company over the remaining 15-year tenure of the existing supply contract.
Key Highlights
Planned investment of ₹200–250 crores over the next two years for upstream integration.
Transitioning to an end-to-end manufacturing model for a key feedstock previously supplied by the customer.
Expected to positively enhance EBITDA margins over the residual 15-year contract tenure.
Project to be situated at the existing Dahej SEZ location in Gujarat.
Strengthens AIL's position as a preferred integrated partner for global chemical majors.
💼 Action for Investors
Investors should view this as a margin-accretive development that improves long-term profitability and supply chain control. Monitor the timely execution of the CAPEX and its impact on operating leverage in future earnings.
Aarti Industries to Invest ₹200-250 Cr for Backward Integration in Long-Term Supply Deal
Aarti Industries has amended its exclusive long-term supply agreement with a global chemical major to include backward integration for a key feedstock. The company will invest ₹200–250 crore over the next two years to set up a manufacturing facility at its Dahej SEZ site. While the move is not expected to materially impact topline growth, it is projected to enhance EBITDA margins over the remaining 15-year contract period. This strategic shift aims to optimize operating expenses and freight costs while strengthening supply chain resilience.
Key Highlights
Planned investment of ₹200–250 crore over the next two years for upstream integration
Facility to be established at the existing Dahej SEZ location in Gujarat
Transitioning to an end-to-end manufacturing model for a high-value specialty chemical intermediate
Expected to improve EBITDA margins over the residual 15-year tenure of the main agreement
Focus on opex and freight optimization through in-house manufacturing versus external sourcing
💼 Action for Investors
Investors should view this as a margin-accretive development that secures long-term profitability and strengthens the company's competitive moat. Monitor the timely execution of the capex and its subsequent impact on operating margins.
Aarti Industries Q3 FY26: PAT Surges 25% Q-o-Q to ₹133 Cr; Exports Hit Record 65% of Revenue
Aarti Industries reported a strong Q3 FY26 performance with revenue growing 11% Q-o-Q to ₹2,492 crore and PAT rising 25% to ₹133 crore. Export contribution reached a record 65% of total revenue, driven by the resumption of US volumes and growth in MMA and DCB products. The company is aggressively expanding MMA capacity to 360 KT by Q4FY26 and has revised its FY26 CAPEX guidance upward to ₹1,100 crore to capture high-return opportunities. Management expects structural tailwinds from the India-US trade deal and China's 'anti-involution' strategy which is curbing chemical dumping.
Key Highlights
Revenue increased 11% Q-o-Q to ₹2,492 crore, while EBITDA rose 11% to ₹323 crore.
PAT surged 25% Q-o-Q to ₹133 crore, despite a ₹15 crore exceptional provision for the new labour code.
MMA capacity is being scaled up from 290+ KT to 360 KT by the end of Q4FY26.
Exports reached an all-time high of 65% of total revenue in both percentage and absolute terms.
FY26 CAPEX guidance increased to ₹1,100 crore from ₹1,000 crore, with FY27 CAPEX expected to be significantly lower.
💼 Action for Investors
Investors should view the volume recovery in the US and the capacity expansions in MMA and DCB as positive growth catalysts. The company's pivot toward high-value advanced materials and the expected margin recovery from reduced Chinese competition make it a strong long-term pick in the specialty chemicals space.
Aarti Industries Q3 FY26: PAT Surges 189% YoY to ₹156 Cr; Revenue Up 22%
Aarti Industries reported a robust Q3 FY26 with revenue growing 22% YoY to ₹2,492 crore and PAT jumping 189% to ₹156 crore. Growth was primarily driven by the resumption of US exports for MMA and PDCB, alongside higher volumes in the energy segment. While margins in the agrochemical and dyes segments remain under pressure from Chinese competition, the company is aggressively expanding MMA capacity to 360 KTPA. Management has revised its FY26 capex guidance upward to ₹1,100 crore and maintains a long-term EBITDA target of ₹1,800-2,200 crore.
Key Highlights
Revenue grew 22% YoY to ₹2,492 crore and EBITDA increased 37% YoY to ₹353 crore.
PAT surged 189% YoY to ₹156 crore, despite an exceptional expense of ₹15.3 crore related to the New Labour Code.
MMA capacity utilization reached 96% with further expansion to 360 KTPA currently underway.
FY26 Capex guidance increased to ₹1,100 crore from the initial ₹1,000 crore to support incremental growth projects.
Management targets a 3-year EBITDA range of ₹1,800-2,200 crore with a Debt/EBITDA ratio below 2.5x.
💼 Action for Investors
Investors should focus on the upcoming commissioning of the Multi-Purpose Plant (MPP) and PEDA projects in Q4 FY26 as immediate growth triggers. The significant bottom-line recovery and volume growth in the energy segment suggest a positive turnaround, though agrochemical margin pressure remains a key risk to monitor.
Aarti Industries Q3 FY26 PAT Jumps 25% Q-o-Q to ₹133 Crore Amid Global Headwinds
Aarti Industries reported a strong sequential recovery in Q3 FY26, with revenue growing 11% Q-o-Q to ₹2,492 crore driven by volume growth and higher capacity utilization. Profit After Tax (PAT) surged 25% Q-o-Q to ₹133 crore, reflecting improved operating leverage and cost-saving initiatives despite global trade uncertainties. The company recorded a one-time exceptional expense of ₹15 crore for the new labor code implementation. Management highlighted the resumption of US volumes and steady demand in the energy segment as key performance drivers.
Key Highlights
Revenue stood at ₹2,492 crore, marking an 11% Q-o-Q increase driven by volume growth across value chains.
EBITDA rose 11% Q-o-Q to ₹323 crore, even after accounting for a ₹15 crore exceptional labor code provision.
PAT increased significantly by 25% Q-o-Q to ₹133 crore, supported by better capacity utilization and cost efficiencies.
Energy business (MMA) remained a primary growth driver with robust volumes and favorable feedstock spreads.
Commissioning of the transformational Zone IV multipurpose plant (MPP) is scheduled to begin in Q4 FY26.
💼 Action for Investors
The strong sequential recovery in margins and PAT indicates that the company is effectively navigating global trade volatility. Investors should watch for the timely commissioning of the Zone IV projects and potential margin expansion from the EU FTA and China policy shifts.
Aarti Industries Q3 PAT Surges 179% YoY to ₹131 Crore; Revenue Up 30%
Aarti Industries reported a robust performance for the quarter ended December 31, 2025, with net profit jumping 178.7% year-on-year to ₹131 crore. Net revenue from operations grew by 30% YoY to ₹2,276 crore, indicating a strong recovery in demand and operational scale. Sequentially, the company maintained momentum with a 9.2% revenue growth and a 29.7% increase in PAT compared to the September 2025 quarter. Despite an exceptional expense of ₹15 crore during the quarter, the bottom line was supported by improved operational efficiencies and lower sequential finance costs.
Key Highlights
Net Profit (PAT) rose to ₹131 crore in Q3 FY26, a significant jump from ₹47 crore in Q3 FY25.
Net Revenue from operations increased 30% YoY to ₹2,276 crore from ₹1,750 crore.
Basic Earnings Per Share (EPS) improved to ₹3.63 from ₹1.31 in the corresponding previous year quarter.
Finance costs saw a sequential reduction to ₹68 crore in Q3 FY26 from ₹98 crore in Q2 FY26.
Nine-month (9M FY26) PAT stands at ₹276 crore, up from ₹240 crore in the same period last year.
💼 Action for Investors
The strong year-on-year recovery in both top-line and bottom-line suggests a positive turnaround in the specialty chemicals cycle for Aarti Industries. Investors should consider this a sign of operational resilience and may look for sustained margin improvements in upcoming quarters.